These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4626940)

  • 1. Optimal intravesical dosage of thio-tepa in the prophylaxis of recurrent bladder papillomatosis.
    Oravisto KJ
    Scand J Urol Nephrol; 1972; 6(1):26-8. PubMed ID: 4626940
    [No Abstract]   [Full Text] [Related]  

  • 2. [Verification of the effectiveness of Thio-Tepa on tumor tissue in local chemotherapy of bladder papillomatosis].
    Lunglmayr G; Kellner G; Czech K
    Urol Int; 1970; 25(5):493-501. PubMed ID: 5004171
    [No Abstract]   [Full Text] [Related]  

  • 3. A prospective randomized study of prophylaxis of tumor recurrence following transurethral resection of superficial bladder cancer--intravesical thio-TEPA versus oral UFT.
    Hirao Y; Okajima E; Ozono S; Samma S; Sasaki K; Hiramatsu T; Babaya K; Watanabe S; Maruyama Y
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S26-30. PubMed ID: 1394812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Instillation of thio-tepa (Tifosyl) in vesical papillomatosis.
    Edsmyr F; Boman J
    Acta Radiol Ther Phys Biol; 1970 Oct; 9(5):395-400. PubMed ID: 4990891
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder.
    Koontz WW; Prout GR; Smith W; Frable WJ; Minnis JE
    J Urol; 1981 Mar; 125(3):307-12. PubMed ID: 6782251
    [No Abstract]   [Full Text] [Related]  

  • 6. [Spontaneously cured pancytopenia due to intravesical thio-tepa, apropos of one case].
    Archimbaud JP; Calcat P; Martel JP
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):487-8. PubMed ID: 4216648
    [No Abstract]   [Full Text] [Related]  

  • 7. Local application of THIO-TEPA in the prevention of recurrent papillary carcinoma of the bladder.
    Csellár M; Csontai A
    Int Urol Nephrol; 1979; 11(1):39-44. PubMed ID: 112079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prophylactic use of thio-tepa and urokinase in transitional cell carcinoma of the bladder: a preliminary report.
    Hisazumi H; Uchibayashi T; Naito K; Misaki T; Miyazaki K
    J Urol; 1975 Sep; 114(3):394-8. PubMed ID: 806708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical thio-tepa in the immediate postoperative period in patients with recurrent transitional cell carcinoma of the bladder.
    Gavrell GJ; Lewis RW; Meehan WL; Leblanc GA
    J Urol; 1978 Oct; 120(4):410-1. PubMed ID: 100615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Own experiences with the treatment of papillomatous bladder neoplasms by intracystic administration of Thio-Tepa].
    Dobrzecki W; Kaczmarek A
    Pol Przegl Chir; 1977 Jun; 49(6a):743-8. PubMed ID: 407554
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intravesical application of thio-tepa for preventing postoperative recurrence of bladder carcinoma].
    Zhang SX; Deng XZ; Tang XD
    Zhonghua Wai Ke Za Zhi; 1986 Aug; 24(8):486-7, 510. PubMed ID: 3102180
    [No Abstract]   [Full Text] [Related]  

  • 12. Thiotepa bladder instillations: therapy and prophylaxis for superficial bladder tumors.
    Veenema RJ; Dean AL; Uson AC; Roberts M; Longo F
    J Urol; 1969 May; 101(5):711-5. PubMed ID: 4976352
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy in superficial neoplasms of the bladder.
    Zingg E; Sulmoni A
    S Afr Med J; 1972 Jul; 46(27):916-7. PubMed ID: 4626807
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cytostatic prophylactic treatment of superficial bladder tumours].
    Lunglmayr G
    Urologe A; 1972 Mar; 11(2):94-7. PubMed ID: 4623214
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of intravesical instillation of Thio-Tepa on the recurrence rate of bladder tumors.
    Asahi T; Matsumura Y; Tanahashi T; Yoshimoto J; Kaneshige T; Fujita Y; Ohmori H
    Acta Med Okayama; 1980 Feb; 34(1):43-9. PubMed ID: 6446839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder hyperthermia in the treatment of vesical papillomatosis.
    Lunglmayr G; Czech K; Zekert F; Kellner G
    Int Urol Nephrol; 1973 Jan; 5(1):75-84. PubMed ID: 4203803
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy for bladder cancer.
    Veenema RJ; Romas NA; Fingerhut B
    Urology; 1974 Feb; 3(2):135-9. PubMed ID: 4204755
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravesical thiotepa in prevention of recurrence of bladder tumour.
    Ghosal SK; Sen DK
    J Indian Med Assoc; 1980 Nov; 75(9):173-4. PubMed ID: 6785360
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravesical thiotepa prophylaxis of superficial bladder cancer. A follow-up study.
    Fosså SD; Miller A; Stenwig AE
    Eur Urol; 1983; 9(4):207-10. PubMed ID: 6409615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thio-tepa in the treatment of vesical papilloma].
    Quénu L
    J Urol Nephrol (Paris); 1971; 77(7):628-9. PubMed ID: 4998059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.